E Fund Management’s Rocket Pharmaceuticals RCKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-14,567
| Closed | -$97.2K | – | 421 |
|
|
2025
Q1 | $97.2K | Buy |
14,567
+3,513
| +32% | +$23.4K | ﹤0.01% | 383 |
|
|
2024
Q4 | $139K | Buy |
+11,054
| New | +$139K | 0.01% | 375 |
|
|
2024
Q2 | – | Sell |
-15,549
| Closed | -$419K | – | 364 |
|
|
2024
Q1 | $419K | Buy |
15,549
+4,352
| +39% | +$117K | 0.03% | 202 |
|
|
2023
Q4 | $336K | Sell |
11,197
-1,215
| -10% | -$36.4K | 0.02% | 219 |
|
|
2023
Q3 | $254K | Sell |
12,412
-120
| -1% | -$2.46K | 0.02% | 223 |
|
|
2023
Q2 | $249K | Sell |
12,532
-4,469
| -26% | -$88.8K | 0.02% | 244 |
|
|
2023
Q1 | $291K | Buy |
17,001
+1,601
| +10% | +$27.4K | 0.02% | 229 |
|
|
2022
Q4 | $301K | Sell |
15,400
-178
| -1% | -$3.48K | 0.03% | 235 |
|
|
2022
Q3 | $249K | Buy |
+15,578
| New | +$249K | 0.02% | 266 |
|